These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6139277)

  • 1. Recurrent pheochromocytoma associated with glucagonoma. A case report.
    Yao H; Fukiyama K; Kawano Y; Mizumoto K; Toyoshima S; Omae T
    Endocrinol Jpn; 1983 Apr; 30(2):163-6. PubMed ID: 6139277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of glucagonoma].
    Numakawa T; Ikeuchi T; Sugimasa T; Inoue S; Takamura Y; Suda T
    Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):977-84. PubMed ID: 6294199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 5. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucagonoma syndrome with a normal blood glucose curve].
    González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
    Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
    [No Abstract]   [Full Text] [Related]  

  • 10. Pheochromocytoma with multiple islet cell carcinoma.
    Tamasawa N; Terada A; Kodama T; Ishigame M; Ishimaru K; Hishida R; Satoh T; Takebe K; Sasaki M; Imamura K
    Presse Med; 1994 Jan 8-15; 23(1):32-4. PubMed ID: 7907420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of malignant glucagonoma with a profile of immunoreactive glucagon before and after the operation].
    Ohtsuka K; Nimura Y; Takaesu H; Yokoi S; Shionoya S; Yasui K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2223-6. PubMed ID: 3029475
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
    Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
    Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent insulinoma syndrome with metastatic glucagonoma.
    Dunn PJ; Sheppard MC; Heath DA; Slaney G
    J Clin Pathol; 1983 Sep; 36(9):1076-80. PubMed ID: 6136529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma.
    Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of bilateral pheochromocytoma and pancreatic islet cell tumor: report of a case and review of the literature.
    Tateishi R; Wada A; Ishiguro S; Ehara M; Sakamoto H; Miki T; Mori Y; Matsui Y; Ishikawa O
    Cancer; 1978 Dec; 42(6):2928-34. PubMed ID: 215301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case with glucagonoma syndrome--endocrine and metabolic studies.
    Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
    Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucagonoma syndrome and its management.
    Kessinger A; Lemon HM; Foley JF
    J Surg Oncol; 1977; 9(5):419-24. PubMed ID: 201809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary prolactinoma, pancreatic glucagonomas, and aldosterone-producing adrenal cortical adenoma: a suggested variant of multiple endocrine neoplasia type I.
    Gould E; Albores-Saavedra J; Shuman J
    Hum Pathol; 1987 Dec; 18(12):1290-3. PubMed ID: 2824331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel changes of atrial natriuretic factor and catecholamines during surgery for pheochromocytoma.
    Donckier J; Michel L; Collard E; Berbinschi A; Ketelslegers JM; Harvengt C; Buysschaert M
    Am J Med; 1988 Aug; 85(2):278-9. PubMed ID: 2899974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple endocrine neoplasia].
    Guan H; Zhu Y; Liu GZ
    Zhonghua Wai Ke Za Zhi; 1987 May; 25(5):287-9, 316-7. PubMed ID: 2890500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.